Literature DB >> 11564876

Molecular basis for impaired muscle differentiation in myotonic dystrophy.

N A Timchenko1, P Iakova, Z J Cai, J R Smith, L T Timchenko.   

Abstract

Differentiation of skeletal muscle is affected in myotonic dystrophy (DM) patients. Analysis of cultured myoblasts from DM patients shows that DM myoblasts lose the capability to withdraw from the cell cycle during differentiation. Our data demonstrate that the expression and activity of the proteins responsible for cell cycle withdrawal are altered in DM muscle cells. Skeletal muscle cells from DM patients fail to induce cytoplasmic levels of a CUG RNA binding protein, CUGBP1, while normal differentiated cells accumulate CUGBP1 in the cytoplasm. In cells from normal patients, CUGBP1 up-regulates p21 protein during differentiation. Several lines of evidence show that CUGBP1 induces the translation of p21 via binding to a GC-rich sequence located within the 5' region of p21 mRNA. Failure of DM cells to accumulate CUGBP1 in the cytoplasm leads to a significant reduction of p21 and to alterations of other proteins responsible for the cell cycle withdrawal. The activity of cdk4 declines during differentiation of cells from control patients, while in DM cells cdk4 is highly active during all stages of differentiation. In addition, DM cells do not form Rb/E2F repressor complexes that are abundant in differentiated cells from normal patients. Our data provide evidence for an impaired cell cycle withdrawal in DM muscle cells and suggest that alterations in the activity of CUGBP1 causes disruption of p21-dependent control of cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564876      PMCID: PMC99869          DOI: 10.1128/MCB.21.20.6927-6938.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  HuR regulates p21 mRNA stabilization by UV light.

Authors:  W Wang; H Furneaux; H Cheng; M C Caldwell; D Hutter; Y Liu; N Holbrook; M Gorospe
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts.

Authors:  P S Sarkar; B Appukuttan; J Han; Y Ito; C Ai; W Tsai; Y Chai; J T Stout; S Reddy
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy.

Authors:  T R Klesert; D H Cho; J I Clark; J Maylie; J Adelman; L Snider; E C Yuen; P Soriano; S J Tapscott
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

4.  Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein alpha mRNA.

Authors:  A L Welm; S L Mackey; L T Timchenko; G J Darlington; N A Timchenko
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

5.  CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms.

Authors:  N A Timchenko; A L Welm; X Lu; L T Timchenko
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

6.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

7.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

8.  A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator.

Authors:  P J Good; Q Chen; S J Warner; D C Herring
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

9.  RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.

Authors:  N A Timchenko; Z J Cai; A L Welm; S Reddy; T Ashizawa; L T Timchenko
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

10.  "Mitotic drive" of expanded CTG repeats in myotonic dystrophy type 1 (DM1).

Authors:  M Khajavi; A M Tari; N B Patel; K Tsuji; D R Siwak; M L Meistrich; N H Terry; T Ashizawa
Journal:  Hum Mol Genet       Date:  2001-04-01       Impact factor: 6.150

View more
  78 in total

Review 1.  RNA-mediated neurodegeneration in repeat expansion disorders.

Authors:  Peter K Todd; Henry L Paulson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

Review 2.  Epigenetic changes and non-coding expanded repeats.

Authors:  Masayuki Nakamori; Charles Thornton
Journal:  Neurobiol Dis       Date:  2010-02-18       Impact factor: 5.996

3.  Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells.

Authors:  Claudia Huichalaf; Keiko Sakai; Bingwen Jin; Karlie Jones; Guo-Li Wang; Benedikt Schoser; Christiane Schneider-Gold; Partha Sarkar; Olivia M Pereira-Smith; Nikolai Timchenko; Lubov Timchenko
Journal:  FASEB J       Date:  2010-05-17       Impact factor: 5.191

4.  RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2.

Authors:  Karlie Jones; Bingwen Jin; Polina Iakova; Claudia Huichalaf; Partha Sarkar; Christiane Schneider-Gold; Benedikt Schoser; Giovanni Meola; Ann-Bin Shyu; Nikolai Timchenko; Lubov Timchenko
Journal:  Am J Pathol       Date:  2011-09-01       Impact factor: 4.307

Review 5.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

Review 6.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

7.  Calreticulin interacts with C/EBPalpha and C/EBPbeta mRNAs and represses translation of C/EBP proteins.

Authors:  Lubov T Timchenko; Polina Iakova; Alana L Welm; Z-J Cai; Nikolai A Timchenko
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 8.  Pathogenic mechanisms of myotonic dystrophy.

Authors:  Johanna E Lee; Thomas A Cooper
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

9.  Reduction of the rate of protein translation in patients with myotonic dystrophy 2.

Authors:  Claudia Huichalaf; Benedikt Schoser; Christiane Schneider-Gold; Bingwen Jin; Partha Sarkar; Lubov Timchenko
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

10.  Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.

Authors:  Guey-Shin Wang; Debra L Kearney; Mariella De Biasi; George Taffet; Thomas A Cooper
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.